Lung Abnormalities Continue Even 2 Years After Severe COVID

Lung Abnormalities Continue Even 2 Years After Severe COVID

Two recent studies confirm lung scarring and other abnormalities occur in many COVID patients — even two years later. The studies were conducted at the Margaret Turner Warwick Center for Fibrosing Lung Disease with Iain Stewart, PhD. as corresponding author and at Tongji Medical College of Huazhong University and led by co-senior authors Qing Ye,…

Read More

Early Stage Lung Cancer Has 80% Survival Rate over 20 years

Early Stage Lung Cancer Has 80% Survival Rate over 20 years

  Results from a study of patients enrolled in the International Early Lung Cancer Action Program (I-ELCAP) were presented at the 2022 Radiological Society of North America (RSNA) annual meeting. The study was led by Claudia Henschke, MD, PhD, of Mount Sinai Icahn School of Medicine in New York City. She and her study members…

Read More

Only 5.8% of People Eligible Receive Lung Cancer Screening

Only 5.8% of People Eligible Receive Lung Cancer Screening

The American Lung Association’s 5th annual “State of Lung Cancer” revealed that only 5.8% of the Americans eligible for low-dose CT lung cancer screening had been screened. The US Preventive Services Task Force guidelines recommendations are: Have a 20-pack-year history (1 pack/day for 20 years, 2 packs/day for 10 years) Are a current smoker or…

Read More

Two Studies Show that Expanded Eligibility for Lung Cancer Screening Doesn’t Eliminate Disparities

Two Studies Show that Expanded Eligibility for Lung Cancer Screening Doesn't Eliminate Disparities

  Although the U.S. Preventive Services Task Force’s (USPSTF)’s 2021 recommendations for expanded eligibility for low-dose CT lung cancer screenings, two studies revealed that expanded eligibility doesn’t translate into increased utilization of low-dose CT lung cancer screenings among Black adults. A study published September 2 in JAMA Network Open states that increasing eligibility alone is…

Read More

CMS Expands LDCT Screening for Lung Cancer

CMS Expands LDCT Screening for Lung Cancer

CMS announced on February 10 their final decision for coverage of low-dose CT lung cancer screenings. The new guidelines lower the screening age from 55 to 50 and reduce the smoking history pack years from 30 to 20. The decision expands eligibility for Medicare beneficiaries so that those from age 50 up to 77 and…

Read More